Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Altered deposition of inhaled nanoparticles in subjects with chronic obstructive pulmonary disease.

Jakobsson JKF, Aaltonen HL, Nicklasson H, Gudmundsson A, Rissler J, Wollmer P, Löndahl J.

BMC Pulm Med. 2018 Aug 6;18(1):129. doi: 10.1186/s12890-018-0697-2.

2.

Airspace Dimension Assessment with nanoparticles reflects lung density as quantified by MRI.

Aaltonen HL, Kindvall SS, Jakobsson JK, Löndahl J, Olsson LE, Diaz S, Zackrisson S, Wollmer P.

Int J Nanomedicine. 2018 May 21;13:2989-2995. doi: 10.2147/IJN.S160331. eCollection 2018.

3.

Deposition of inhaled nanoparticles is reduced in subjects with COPD and correlates with the extent of emphysema: proof of concept for a novel diagnostic technique.

Aaltonen HL, Jakobsson JK, Diaz S, Zackrisson S, Piitulainen E, Löndahl J, Wollmer P.

Clin Physiol Funct Imaging. 2018 Apr 10. doi: 10.1111/cpf.12517. [Epub ahead of print]

PMID:
29635884
4.

Core curriculum case illustration: cardiac tamponade complicating proximal aortic dissection.

Aaltonen HL, Linnau KF, Fadl SA.

Emerg Radiol. 2019 Oct;26(5):587-589. doi: 10.1007/s10140-017-1525-3. Epub 2017 Jun 14.

PMID:
28616788
5.

Do nanoparticles provide a new opportunity for diagnosis of distal airspace disease?

Löndahl J, Jakobsson JK, Broday DM, Aaltonen HL, Wollmer P.

Int J Nanomedicine. 2016 Dec 19;12:41-51. doi: 10.2147/IJN.S121369. eCollection 2017.

Supplemental Content

Loading ...
Support Center